SMTL ID : 2fbr.1

Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (4 carbon linker)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.46 Å

Oligo State

homo-tetramer

Ligands

2 x 44C: 4'-(4-{4-[(2-CARBOXYPHENYL)AMINO]PHENOXY}BUTOXY)-1,1'-BIPHENYL-4-CARBOXYLIC ACID(Non-covalent)

44C.1: 22 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain B: K.15, L.17, A.108, L.110, S.117, T.119 Chain C: K.15, L.17, A.108, L.110, S.117 Chain D: K.15, L.17, L.110, S.117 Ligands: 44C.2 24 PLIP interactions: 7 interactions with chain A, 5 interactions with chain D, 6 interactions with chain C, 6 interactions with chain B Hydrophobic interactions: A:L.17, A:L.110, A:L.110, D:L.17, D:L.110, C:K.15, C:L.17, C:A.108, C:L.110, B:L.17, B:A.108, B:L.110 Hydrogen bonds: A:A.109, A:S.117, C:S.117, B:S.117 Water bridges: A:V.16, D:K.15, D:K.15, B:K.15 Salt bridges: A:K.15, D:K.15, C:K.15, B:K.15 44C.2: 22 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117 Chain B: K.15, L.17, L.110, S.117 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Chain D: K.15, L.17, A.108, L.110, S.117, T.119 Ligands: 44C.1 24 PLIP interactions: 6 interactions with chain A, 6 interactions with chain D, 7 interactions with chain C, 5 interactions with chain B Hydrophobic interactions: A:K.15, A:L.17, A:A.108, A:L.110, D:L.17, D:A.108, D:L.110, C:L.17, C:L.110, C:L.110, B:L.17, B:L.110 Hydrogen bonds: A:S.117, D:S.117, C:A.109, C:S.117 Salt bridges: A:K.15, D:K.15, C:K.15, B:K.15 Water bridges: D:K.15, C:V.16, B:K.15, B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Green, N.S. et al., Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. J.Am.Chem.Soc. (2003)

Release Date

2005-12-27

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence